Results 31 to 40 of about 68,882 (316)

COVID‐19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?

open access: yesJournal of Internal Medicine, 2020
COVID‐19 is caused by SARS‐CoV‐2, a betacoronavirus that uses the angiotensin‐converting enzyme‐related carboxypeptidase (ACE2) receptor to gain entry into cells. ACE2 receptor is widely expressed in multiple organs, including the retina, an extension of
M. Landecho   +6 more
semanticscholar   +1 more source

Remote Diffusion-Weighted Imaging Lesions in Intracerebral Hemorrhage: Characteristics, Mechanisms, Outcomes, and Therapeutic Implications

open access: yesFrontiers in Neurology, 2017
Spontaneous intracerebral hemorrhage (ICH) is one of the most fatal form of stroke, with high mortality and disability rate. Small diffusion-weighed imaging lesions are not rare to see in regions remote from the hematoma after ICH and have been generally
Xu-hua Xu   +6 more
doaj   +1 more source

Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy—Either, Neither, or Both

open access: yesSeminars in Thrombosis and Hemostasis, 2020
Patients with severe coronavirus disease 2019 (COVID-19) infections manifest coagulation abnormalities that have been associated with respiratory deterioration and death.1,2 In addition, many patients with severe COVID-19 infections develop venous ...
M. Levi, J. Thachil
semanticscholar   +1 more source

Features of the Pathogenetic Mechanisms of Regional Blood Flow Disturbances in Diabetic Foot Syndrome (Lliterature Review)

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2015
Diabetes mellitus (DM) is recognized as one of the most important noninfectious disease in the world, the prevalence of which became pandemic. In the list of late complications of DM, diabetic foot syndrome is a leader, causing early disability and high ...
О.B. Rusak
doaj   +1 more source

Homocysteine in cerebrovascular disease: An independent risk factor for subcortical vascular encephalopathy [PDF]

open access: yes, 2001
Hyperhomocysteinemia is a risk factor for obstructive large-vessel disease. Here, we studied plasma concentrations of homocysteine and vitamins in patients suffering from subcortical vascular encephalopathy (SVE), a cerebral small-vessel disease leading ...
Aufenanger, Johannes   +10 more
core   +1 more source

A case of “smoldering” immune‐mediated thrombotic thrombocytopenic purpura manifesting as recurrent cardioembolic stroke

open access: yesClinical Case Reports, 2021
Prompt recognition and treatment for thrombotic thrombocytopenic purpura (TTP) are critical to prevent the irreversible manifestations of this rare and quickly fatal hematologic disorder.
Mark E. Pepin   +3 more
doaj   +1 more source

How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome [PDF]

open access: yes, 2014
Thrombotic thrombocytopenic purpura (TTP) and atypical haemolytic uraemic syndrome (aHUS) are acute, rare life-threatening thrombotic microangiopathies that require rapid diagnosis and treatment.
Goodship, T, Scully, M
core   +1 more source

COVID-19, microangiopathy, hemostatic activation, and complement.

open access: yesJournal of Clinical Investigation, 2020
In COVID-19, complement activation may contribute to hemostatic activation leading to pathological features such as microvascular injury and coagulopathy.
W. Song, G. FitzGerald
semanticscholar   +1 more source

Unraveling the Role of Allo-Antibodies and Transplant Injury. [PDF]

open access: yes, 2016
Alloimmunity driving rejection in the context of solid organ transplantation can be grossly divided into mechanisms predominantly driven by either T cell-mediated rejection (TCMR) and antibody-mediated rejection (ABMR), though the co-existence of both ...
Matsuda, Yoshiko, Sarwal, Minnie M
core   +2 more sources

Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy

open access: yesBritish Journal of Haematology, 2020
Transplant‐associated thrombotic microangiopathy (TA‐TMA) is a complication of allogeneic transplantation (allo‐HCT). The incidence and risk factors associated with TA‐TMA are not well known.
N. Epperla   +19 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy